Clovis Oncology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CLVSQ and buy or sell other stocks, ETFs, and their options commission-free!

About CLVSQ

Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. 

CEO
Patrick J. Mahaffy
CEOPatrick J. Mahaffy
Employees
Employees
Headquarters
Boulder, Colorado
HeadquartersBoulder, Colorado
Founded
2009
Founded2009
Employees
Employees

CLVSQ Key Statistics

Market cap
2.17M
Market cap2.17M
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$2.87
52 Week high$2.87
52 Week low
$0.0102
52 Week low$0.0102

People also own

Based on the portfolios of people who own CLVSQ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.